Bleeding in lungs treatment study
Part of Lungs & breathing clinical trials.
This study tests a procedure to stop bleeding in the lungs. It may help people who are coughing up blood that hasn't stopped with other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Are 18 years or older.
- Have been diagnosed with bleeding in the lungs.
- Have coughed up at least a small amount of blood (about 2 tablespoons) at least once.
- Are scheduled to have a procedure to find and treat the bleeding.
- Can give written permission to join the study and follow up for 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of giving tranexamic acid, a medicine that helps blood clot, to stop bleeding in the lungs. One way is through a breathing mist (inhaled), and the other is through a vein (IV). The goal is to see which method works better and is safer for people who are coughing up blood.
This study tests two ways to give a medicine called tranexamic acid (which helps blood clot) to people who are coughing up blood. One way is through a nebulizer (breathing in a mist), and the other is through an IV (into a vein). The goal is to see which method works better to stop the bleeding.
This Phase 3 study tests whether inhaled tranexamic acid can reduce lung bleeding (pulmonary hemorrhage) in people with cancer who are on a breathing machine. If you qualify, you may receive the study drug to help stop bleeding in the lungs.
This study looks at whether a procedure called EBUS (a camera passed through the airway) can help doctors diagnose an acute pulmonary embolism—a sudden blood clot in the lungs—in critically ill, intubated ICU patients. If you’re eligible, EBUS may be done during bronchoscopy as part of your usual care to help confirm or rule out the diagnosis.
This trial tests if apixaban, a blood thinner pill, can prevent dangerous blood clots in people with advanced lung cancer who are receiving outpatient chemotherapy or other systemic treatments. It aims to reduce the risk of venous thromboembolism (blood clots in veins) during cancer therapy.
This study tests a procedure to remove blood clots from the lungs in people with moderate or severe pulmonary embolism. It may help reduce strain on the heart and improve recovery.
Hear when a new Hemoptysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.